When Should You Consider Hormone Therapy? A Decision Framework

There's no lab value that tells you it's time for hormone therapy. The decision rests on a handful of practical questions: How much are symptoms actually disrupting your life? Where are you relative to menopause onset? Does your medical history raise any red flags? And have you weighed the alternatives? This article walks through that framework—the same broad logic clinicians use—so you can arrive at an appointment prepared rather than starting from scratch.

Step 1: How Disruptive Are Your Symptoms?

FDA-approved systemic hormone therapies are indicated for moderate-to-severe vasomotor symptoms—hot flashes and night sweats frequent or intense enough to interfere with sleep, work, or daily functioning. Mild, occasional symptoms often don't justify prescription treatment; severe symptoms that wake you nightly or derail your workday usually warrant a conversation. Useful signals that symptoms have crossed the threshold include:

• Hot flashes or night sweats occurring most days, or repeatedly disrupting sleep
• Fatigue, irritability, or trouble concentrating that traces back to broken sleep
• Vaginal dryness or pain with intimacy that doesn't improve with over-the-counter moisturizers
• Symptoms causing you to change plans, performance, or routines

If your main complaint is genitourinary—dryness, irritation, urinary symptoms—low-dose local vaginal estrogen treats those directly with minimal systemic absorption, which changes the risk conversation considerably.

Step 2: Where Are You in the Timing Window?

Timing is one of the most evidence-driven parts of this decision. According to The Menopause Society's 2022 position statement, for healthy women under 60 or within 10 years of menopause onset, the benefit-risk ratio of hormone therapy is generally favorable for treating bothersome hot flashes and preventing bone loss. Started more than 10 years after menopause or after age 60, the balance is less favorable because absolute risks of coronary heart disease, stroke, and blood clots rise. That doesn't make therapy automatic inside the window or impossible outside it—but your distance from menopause onset is a question your clinician will ask early, so know your timeline.

Step 3: Do You Have Contraindications?

Some histories shift the calculation significantly or rule out systemic hormone therapy. Be ready to discuss any history of breast or endometrial cancer, blood clots (deep vein thrombosis or pulmonary embolism), stroke or heart attack, unexplained vaginal bleeding, or active liver disease. None of this is a judgment call you should make alone from a list on a website—it's precisely what an individualized clinical evaluation is for, and it's why reputable telehealth HRT services route every plan through a licensed clinician who reviews your history first.

Step 4: Have You Considered the Alternatives?

Hormone therapy is the most effective treatment for vasomotor symptoms, but it isn't the only option. Nonhormonal prescription approaches (including certain SSRIs/SNRIs, gabapentin, and the newer neurokinin-receptor antagonists), lifestyle measures, and cognitive behavioral therapy for insomnia can all help, particularly for people who can't or prefer not to take hormones. Knowing the alternatives exist keeps the decision a genuine choice rather than a default.

Questions Worth Asking a Clinician

Whether you see a local provider or use a telehealth service, a few questions surface the information that matters most:

• Given my age, timing, and history, do benefits likely outweigh risks for me?
• Would a systemic or local (vaginal) option fit my symptoms better?
• Are you prescribing an FDA-approved product or a compounded one—and why?
• What dose and route would we start with, and how will we reassess?
• What symptoms or side effects should prompt me to call you?

If a provider can't answer these clearly—or promises results without reviewing your history—that's a reason to keep comparing.